Aleor Dermaceuticals has received final approval from the US Food and Drug Administration (USFDA) for its abbreviated new drug application (ANDA) for Tavaborole Topical Solution, 5 per cent, Alembic Pharmaceuticals said in a BSE filing.from Healthcare/Biotech-Industry-Economic Times https://ift.tt/31s5pX1
via IFTTT
0 comments:
Post a Comment